Microbion Corporation (Microbion) is an emerging anti-infective pharmaceutical (drug development) and medical device coating company, focused on the commercialization of our proprietary technology - a novel class of anti-infective, anti-biofilm compounds with a new mechanism of action. We employ a licensing and co-development business model to advance commercialization of this platform technology.
We are scheduled to enter Phase I clinical studies for our first drug candidate this year. We have also established an out-license agreement with a large US medical device company that is currently engaged in the FDA regulatory process.